4.6 Article

Efficacy of Zidovudine-Amikacin Combination Therapy In Vitro and in a Rat Tissue Cage Infection Model against Amikacin-Resistant, Multidrug-Resistant Enterobacteriales

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Zidovudine in synergistic combination with fosfomycin: an in vitro and in vivo evaluation against multidrug-resistant Enterobacterales

Roberta Maria Antonello et al.

Summary: The study assessed the effect of the combination of fosfomycin and zidovudine against clinical MDR Enterobacterales isolates, showing synergistic activity in most tested strains and restoration of sensitivity in fosfomycin-resistant strains. Animal experiments confirmed the enhanced effectiveness of this combination therapy.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)

Article Infectious Diseases

In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae

Wentao Ni et al.

Summary: The study found synergistic or partial synergistic activity between tigecycline and aminoglycosides against CR-KP. Combination therapies showed better therapeutic effectiveness compared to monotherapy for susceptible isolates, indicating in vivo synergistic effects. Additionally, the combination of tigecycline with an aminoglycoside significantly reduced the occurrence of tigecycline-resistant mutants.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Infectious Diseases

Zidovudine enhances activity of carbapenems against NDM-1-producing Enterobacteriaceae

Yanmin Hu et al.

Summary: The combination of zidovudine and carbapenems showed significant synergistic activity against NDM-1 Enterobacteriaceae strains in vitro.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Microbiology

Characterization of Amikacin Drug Exposure and Nephrotoxicity in an Animal Model

Katrina Chan et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Infectious Diseases

High-Level Resistance to Aminoglycosides due to 16S rRNA Methylation in Enterobacteriaceae Isolates

Fatemeh Yeganeh Sefidan et al.

MICROBIAL DRUG RESISTANCE (2019)

Review Immunology

Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria

Lucie Peyclit et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Article Infectious Diseases

Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections

S. M. S. Ng et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)

Editorial Material Infectious Diseases

Zidovudine: A salvage therapy for mcr-1 plasmid-mediated colistin-resistant bacterial infections?

Lucie Peyclit et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)

Review Microbiology

Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

Li-Yang Hsu et al.

CLINICAL MICROBIOLOGY REVIEWS (2017)

Review Biochemistry & Molecular Biology

Amikacin: Uses, Resistance, and Prospects for Inhibition

Maria S. Ramirez et al.

MOLECULES (2017)

Article Infectious Diseases

Outbreak of NDM-1-producing Klebsiella pneumoniae ST76 and ST37 isolates in neonates

J. Zhu et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)

Review Infectious Diseases

Options for treating carbapenem-resistant Enterobacteriaceae

Petros I. Rafailidis et al.

CURRENT OPINION IN INFECTIOUS DISEASES (2014)

Review Microbiology

When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing

Christopher D. Doern

JOURNAL OF CLINICAL MICROBIOLOGY (2014)

Article Immunology

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Neil Gupta et al.

CLINICAL INFECTIOUS DISEASES (2011)

Article Infectious Diseases

Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers

Beatrice Bercot et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)

Article Infectious Diseases

Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains

A. Doleans-Jordheim et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)

Review Pharmacology & Pharmacy

Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine

Tomas Cihlar et al.

ANTIVIRAL RESEARCH (2010)

Review Pharmacology & Pharmacy

Aminoglycoside modifying enzymes

Maria S. Ramirez et al.

DRUG RESISTANCE UPDATES (2010)

Review Pharmacology & Pharmacy

Novel approaches to developing new antibiotics for bacterial infections

A. R. M. Coates et al.

BRITISH JOURNAL OF PHARMACOLOGY (2007)

Article Microbiology

Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme

Chi Hye Park et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)

Review Infectious Diseases

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

Jian Li et al.

LANCET INFECTIOUS DISEASES (2006)

Article Biochemical Research Methods

Simultaneous determination of zidovudine and lamivudine from rat plasma, amniotic fluid and tissues by HPLC

Y Alnouti et al.

BIOMEDICAL CHROMATOGRAPHY (2004)